mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis. Barzen G, Rieber F, Stangl K, Hahn K, et al. Vaccine 2023 Dec 28:S0264-410X(23)01487-1. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Barzen G, Rieber F, Stangl K, Hahn K, et al. mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis. Vaccine 2023 Dec 28:S0264-410X(23)01487-1. doi: 10.1016/j.vaccine.2023.
PMID: 38158299